TY - JOUR
T1 - Ashared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphoma
AU - Bieging, Kathryn T.
AU - Fish, Kamonwan
AU - Bondada, Subbarao
AU - Longnecker, Richard
PY - 2011/12/22
Y1 - 2011/12/22
N2 - The link between EBV infection and Burkitt lymphoma (BL) is strong, but the mechanism underlying that link has been elusive. We have developed a mouse model for EBV-associated BL in which LMP2A, an EBV latency protein, and MYC are expressed in B cells. Our model has demonstrated the ability of LMP2A to accelerate tumor onset, increase spleen size, and bypass p53 inactivation. Here we describe the results of total gene expression analysis of tumor and pretumor B cells from our transgenic mouse model. Although we see many phenotypic differences and changes in gene expression in pretumor B cells, the transcriptional profiles of tumor cells from LMP2A/λ-MYC and λ-MYC mice are strikingly similar, with fewer than 20 genes differentially expressed.We evaluated the functional significance of one of the most interesting differentially expressed genes, Egr1, and found that it was not required for acceleration of tumor onset by LMP2A. Our studies demonstrate the remarkable ability of LMP2A to affect the pretumor B-cell phenotype and tumorigenesis without substantially altering gene expression in tumor cells.
AB - The link between EBV infection and Burkitt lymphoma (BL) is strong, but the mechanism underlying that link has been elusive. We have developed a mouse model for EBV-associated BL in which LMP2A, an EBV latency protein, and MYC are expressed in B cells. Our model has demonstrated the ability of LMP2A to accelerate tumor onset, increase spleen size, and bypass p53 inactivation. Here we describe the results of total gene expression analysis of tumor and pretumor B cells from our transgenic mouse model. Although we see many phenotypic differences and changes in gene expression in pretumor B cells, the transcriptional profiles of tumor cells from LMP2A/λ-MYC and λ-MYC mice are strikingly similar, with fewer than 20 genes differentially expressed.We evaluated the functional significance of one of the most interesting differentially expressed genes, Egr1, and found that it was not required for acceleration of tumor onset by LMP2A. Our studies demonstrate the remarkable ability of LMP2A to affect the pretumor B-cell phenotype and tumorigenesis without substantially altering gene expression in tumor cells.
UR - http://www.scopus.com/inward/record.url?scp=84255160933&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84255160933&partnerID=8YFLogxK
U2 - 10.1182/blood-2011-02-338434
DO - 10.1182/blood-2011-02-338434
M3 - Article
C2 - 22039254
AN - SCOPUS:84255160933
SN - 0006-4971
VL - 118
SP - 6849
EP - 6859
JO - Blood
JF - Blood
IS - 26
ER -